Literature DB >> 25835729

Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host.

Richard J Kuhn1, Kimberly A Dowd2, Carol Beth Post3, Theodore C Pierson4.   

Abstract

Remarkable progress in structural biology has equipped virologists with insight into structures of viral proteins and virions at increasingly high resolution. Structural information has been used extensively to address fundamental questions about virtually all aspects of how viruses replicate in cells, interact with the host, and in the design of antiviral compounds. However, many critical aspects of virology exist outside the snapshots captured by traditional methods used to generate high-resolution structures. Like all proteins, viral proteins are not static structures. The conformational flexibility and dynamics of proteins play a significant role in protein-protein interactions, and in the structure and biology of virus particles. This review will discuss the implications of the dynamics of viral proteins on the biology, antigenicity, and immunogenicity of flaviviruses. Published by Elsevier Inc.

Entities:  

Keywords:  Antibody-mediated neutralization; Dengue virus; Flavivirus; Structural dynamics; Viral breathing; West Nile virus

Mesh:

Substances:

Year:  2015        PMID: 25835729      PMCID: PMC4900690          DOI: 10.1016/j.virol.2015.03.025

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  124 in total

1.  Structure of West Nile virus.

Authors:  Suchetana Mukhopadhyay; Bong-Suk Kim; Paul R Chipman; Michael G Rossmann; Richard J Kuhn
Journal:  Science       Date:  2003-10-10       Impact factor: 47.728

2.  Stabilization of human rhinovirus serotype 2 against pH-induced conformational change by antiviral compounds.

Authors:  M Gruenberger; D Pevear; G D Diana; E Kuechler; D Blaas
Journal:  J Gen Virol       Date:  1991-02       Impact factor: 3.891

3.  Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody.

Authors:  Mickaël V Cherrier; Bärbel Kaufmann; Grant E Nybakken; Shee-Mei Lok; Julia T Warren; Beverly R Chen; Christopher A Nelson; Victor A Kostyuchenko; Heather A Holdaway; Paul R Chipman; Richard J Kuhn; Michael S Diamond; Michael G Rossmann; Daved H Fremont
Journal:  EMBO J       Date:  2009-08-27       Impact factor: 11.598

4.  Long-distance correlations of rhinovirus capsid dynamics contribute to uncoating and antiviral activity.

Authors:  Amitava Roy; Carol Beth Post
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-21       Impact factor: 11.205

5.  Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.

Authors:  Soila Sukupolvi-Petty; S Kyle Austin; Michael Engle; James D Brien; Kimberly A Dowd; Katherine L Williams; Syd Johnson; Rebeca Rico-Hesse; Eva Harris; Theodore C Pierson; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

6.  An immunodominant N-terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution.

Authors:  M Roivainen; L Piirainen; T Rysä; A Närvänen; T Hovi
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

7.  The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

Authors:  Bimmi Shrestha; James D Brien; Soila Sukupolvi-Petty; S Kyle Austin; Melissa A Edeling; Taekyung Kim; Katie M O'Brien; Christopher A Nelson; Syd Johnson; Daved H Fremont; Michael S Diamond
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

Review 8.  The structural immunology of antibody protection against West Nile virus.

Authors:  Michael S Diamond; Theodore C Pierson; Daved H Fremont
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

9.  Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.

Authors:  Johanna Jarmer; Jürgen Zlatkovic; Georgios Tsouchnikas; Oksana Vratskikh; Judith Strauß; Judith H Aberle; Vaclav Chmelik; Michael Kundi; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

10.  A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface.

Authors:  Guntur Fibriansah; Joanne L Tan; Scott A Smith; Adamberage R de Alwis; Thiam-Seng Ng; Victor A Kostyuchenko; Kristie D Ibarra; Jiaqi Wang; Eva Harris; Aravinda de Silva; James E Crowe; Shee-Mei Lok
Journal:  EMBO Mol Med       Date:  2014-01-13       Impact factor: 12.137

View more
  54 in total

1.  Dengue virus: Bumps in the road to therapeutic antibodies.

Authors:  Leslie Goo; Theodore C Pierson
Journal:  Nature       Date:  2015-08-20       Impact factor: 49.962

Review 2.  Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials.

Authors:  Aravinda M de Silva; Eva Harris
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

Review 3.  Biochemistry and Molecular Biology of Flaviviruses.

Authors:  Nicholas J Barrows; Rafael K Campos; Kuo-Chieh Liao; K Reddisiva Prasanth; Ruben Soto-Acosta; Shih-Chia Yeh; Geraldine Schott-Lerner; Julien Pompon; October M Sessions; Shelton S Bradrick; Mariano A Garcia-Blanco
Journal:  Chem Rev       Date:  2018-04-13       Impact factor: 60.622

4.  Conformational landscape of a virus by single-particle X-ray scattering.

Authors:  Ahmad Hosseinizadeh; Ghoncheh Mashayekhi; Jeremy Copperman; Peter Schwander; Ali Dashti; Reyhaneh Sepehr; Russell Fung; Marius Schmidt; Chun Hong Yoon; Brenda G Hogue; Garth J Williams; Andrew Aquila; Abbas Ourmazd
Journal:  Nat Methods       Date:  2017-08-14       Impact factor: 28.547

5.  Flaviviruses have imperfect icosahedral symmetry.

Authors:  Matthew D Therkelsen; Thomas Klose; Frank Vago; Wen Jiang; Michael G Rossmann; Richard J Kuhn
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

6.  Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus.

Authors:  April M Clayton
Journal:  J Infect Dis       Date:  2016-12-15       Impact factor: 5.226

7.  Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype.

Authors:  Kimberly A Dowd; Christina R DeMaso; Rebecca S Pelc; Scott D Speer; Alexander R Y Smith; Leslie Goo; Derek J Platt; John R Mascola; Barney S Graham; Mark J Mulligan; Michael S Diamond; Julie E Ledgerwood; Theodore C Pierson
Journal:  Cell Rep       Date:  2016-07-29       Impact factor: 9.423

Review 8.  Mapping the diverse structural landscape of the flavivirus antibody repertoire.

Authors:  Madhumati Sevvana; Richard J Kuhn
Journal:  Curr Opin Virol       Date:  2020-08-13       Impact factor: 7.090

9.  Exploring Evolutionary Constraints in the Proteomes of Zika, Dengue, and Other Flaviviruses to Find Fitness-Critical Sites.

Authors:  Janelle Nunez-Castilla; Jordon Rahaman; Joseph B Ahrens; Christian A Balbin; Jessica Siltberg-Liberles
Journal:  J Mol Evol       Date:  2020-04-07       Impact factor: 2.395

10.  A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.

Authors:  Amanda E Calvert; Kandice L Dixon; Joseph Piper; Susan L Bennett; Brett A Thibodeaux; Alan D T Barrett; John T Roehrig; Carol D Blair
Journal:  Antiviral Res       Date:  2016-04-26       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.